A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
Public ClinicalTrials.gov record NCT00002156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the clinically safe and effective dose of intravitreal ISIS 2922 alone and as an additive antiviral therapy to ganciclovir in AIDS patients with cytomegalovirus (CMV) retinitis.
Study identification
- NCT ID
- NCT00002156
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 194 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina - Vitreous Associates Med Group | Los Angeles | California | 90017 | — |
| Community Eye Med Group | Pasadena | California | 911052536 | — |
| San Diego Naval Hosp | San Diego | California | 92134 | — |
| Univ of California San Francisco / SF Gen Hosp | San Francisco | California | 94110 | — |
| Santa Clara Valley Med Ctr | San Jose | California | 95128 | — |
| Univ of Colorado Health Sciences Ctr | Denver | Colorado | 80262 | — |
| Dr Julio Perez | Fort Lauderdale | Florida | 33060 | — |
| Georgia Retina | Atlanta | Georgia | 30327 | — |
| Univ of Illinois | Chicago | Illinois | 60612 | — |
| Indiana Univ Med Ctr | Indianapolis | Indiana | 46202 | — |
| Vitreo - Retinal Consultants | New York | New York | 10028 | — |
| Charlotte Eye Ear Nose and Throat Association | Charlotte | North Carolina | 28204 | — |
| Hahnemann Univ Hosp | Philadelphia | Pennsylvania | 19102 | — |
| Graduate Hosp | Philadelphia | Pennsylvania | 191461192 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 752359057 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23507 | — |
| Novum Inc | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002156 live on ClinicalTrials.gov.